Chronic Oxytocin Administration as a Treatment Against Impaired Leptin Signaling or Leptin Resistance in Obesity

Frontiers in Endocrinology

Volumn 6, Issue , 2015, Pages

  Altirriba, Jordi ^a   Poher, Anne Laure ^a   Rohner Jeanrenaud, Françoise ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

adipocyte; diabetes; leptin; obesity; oxytocin

Indexed keywords

EID: 84984906464     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2015.00119     Document Type: Review

References (77)

1. World Health Organization. Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks. Geneva: World Health Organization (2009). Available from: http://www.who.int/healthinfo/global_burden_disease/GlobalHealthRisks_report_full.pdf
2. Wang YC Colditz GA Kuntz KM. Forecasting the obesity epidemic in the aging U.S. population. Obesity (Silver Spring) (2007) 15:2855–65.10.1038/oby.2007.33918070778
3. Daviglus ML Liu K Yan LL Pirzada A Manheim L Manning W et al. Relation of body mass index in young adulthood and middle age to Medicare expenditures in older age. JAMA (2004) 292:2743–9.10.1001/jama.292.22.274315585734
4. Blevins JE Ho JM. Role of oxytocin signaling in the regulation of body weight. Rev Endocr Metab Disord (2013) 14:311–29.10.1007/s11154-013-9260-x24065622
5. Gimpl G Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiol Rev (2001) 81:629–83.11274341
6. McEwen BB. General introduction to vasopressin and oxytocin: structure/metabolism, evolutionary aspects, neural pathway/receptor distribution, and functional aspects relevant to memory processing. Adv Pharmacol (2004) 50(1–50):655–708.10.1016/S1054-3589(04)50001-7
7. Maejima Y Sakuma K Santoso P Gantulga D Katsurada K Ueta Y et al. Oxytocinergic circuit from paraventricular and supraoptic nuclei to arcuate POMC neurons in hypothalamus. FEBS Lett (2014) 588:4404–12.10.1016/j.febslet.2014.10.01025448678
8. Kiss A Mikkelsen JD. Oxytocin – anatomy and functional assignments: a minireview. Endocr Regul (2005) 39:97–105.16468232
9. Arletti R Benelli A Bertolini A. Influence of oxytocin on feeding behavior in the rat. Peptides (1989) 10:89–93.10.1016/0196-9781(89)90082-X2748428
10. Klockars A Levine AS Olszewski PK. Central oxytocin and food intake: focus on macronutrient-driven reward. Front Endocrinol (2015) 6:65.10.3389/fendo.2015.0006525972841
11. Takayanagi Y Kasahara Y Onaka T Takahashi N Kawada T Nishimori K. Oxytocin receptor-deficient mice developed late-onset obesity. Neuroreport (2008) 19:951–5.10.1097/WNR.0b013e3283021ca918520999
12. Camerino C. Low sympathetic tone and obese phenotype in oxytocin-deficient mice. Obesity (Silver Spring) (2009) 17:980–4.10.1038/oby.2009.1219247273
13. Kasahara Y Takayanagi Y Kawada T Itoi K Nishimori K. Impaired thermoregulatory ability of oxytocin-deficient mice during cold-exposure. Biosci Biotechnol Biochem (2007) 71:3122–6.10.1271/bbb.7049818071238
14. Swaab DF Purba JS Hofman MA. Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader-Willi syndrome: a study of five cases. J Clin Endocrinol Metab (1995) 80:573–9.10.1210/jcem.80.2.78525237852523
15. Kublaoui BM Gemelli T Tolson KP Wang Y Zinn AR. Oxytocin deficiency mediates hyperphagic obesity of Sim1 haploinsufficient mice. Mol Endocrinol (2008) 22:1723–34.10.1210/me.2008-006718451093
16. Bonnefond A Raimondo A Stutzmann F Ghoussaini M Ramachandrappa S Bersten DC et al. Loss-of-function mutations in SIM1 contribute to obesity and Prader-Willi-like features. J Clin Invest (2013) 123:3037–41.10.1172/JCI6803523778136
17. Hakansson ML Brown H Ghilardi N Skoda RC Meister B. Leptin receptor immunoreactivity in chemically defined target neurons of the hypothalamus. J Neurosci (1998) 18:559–72.9412531
18. Elmquist JK Ahima RS Maratos-Flier E Flier JS Saper CB. Leptin activates neurons in ventrobasal hypothalamus and brainstem. Endocrinology (1997) 138:839–42.10.1210/endo.138.2.50339003024
19. Blevins JE Schwartz MW Baskin DG. Evidence that paraventricular nucleus oxytocin neurons link hypothalamic leptin action to caudal brain stem nuclei controlling meal size. Am J Physiol Regul Integr Comp Physiol (2004) 287:R87–96.10.1152/ajpregu.00604.200315044184
20. Perello M Raingo J. Leptin activates oxytocin neurons of the hypothalamic paraventricular nucleus in both control and diet-induced obese rodents. PLoS One (2013) 8:e59625.10.1371/journal.pone.005962523527232
21. Maejima Y Sedbazar U Suyama S Kohno D Onaka T Takano E et al. Nesfatin-1-regulated oxytocinergic signaling in the paraventricular nucleus causes anorexia through a leptin-independent melanocortin pathway. Cell Metab (2009) 10:355–65.10.1016/j.cmet.2009.09.00219883614
22. Iwasaki Y Maejima Y Suyama S Yoshida M Arai T Katsurada K et al. Peripheral oxytocin activates vagal afferent neurons to suppress feeding in normal and leptin-resistant mice: a route for ameliorating hyperphagia and obesity. Am J Physiol (2015) 308:R360–9.10.1152/ajpregu.00344.201425540101
23. Tung YC Ma M Piper S Coll A O’Rahilly S Yeo GS. Novel leptin-regulated genes revealed by transcriptional profiling of the hypothalamic paraventricular nucleus. J Neurosci (2008) 28:12419–26.10.1523/JNEUROSCI.3412-08.200819020034
24. Wu Z Xu Y Zhu Y Sutton AK Zhao R Lowell BB et al. An obligate role of oxytocin neurons in diet induced energy expenditure. PLoS One (2012) 7:e45167.10.1371/journal.pone.004516723028821
25. Matarazzo V Schaller F Nedelec E Benani A Penicaud L Muscatelli F et al. Inactivation of Socs3 in the hypothalamus enhances the hindbrain response to endogenous satiety signals via oxytocin signaling. J Neurosci (2012) 32:17097–107.10.1523/JNEUROSCI.1669-12.201223197703
26. Wang L Barachina MD Martinez V Wei JY Tache Y. Synergistic interaction between CCK and leptin to regulate food intake. Regul Pept (2000) 92:79–85.10.1016/S0167-0115(00)00153-111024569
27. Olson BR Drutarosky MD Stricker EM Verbalis JG. Brain oxytocin receptor antagonism blunts the effects of anorexigenic treatments in rats: evidence for central oxytocin inhibition of food intake. Endocrinology (1991) 129:785–91.10.1210/endo-129-2-7851649746
28. Blevins JE Eakin TJ Murphy JA Schwartz MW Baskin DG. Oxytocin innervation of caudal brainstem nuclei activated by cholecystokinin. Brain Res (2003) 993:30–41.10.1016/j.brainres.2003.08.03614642828
29. Baskin DG Kim F Gelling RW Russell BJ Schwartz MW Morton GJ et al. A new oxytocin-saporin cytotoxin for lesioning oxytocin-receptive neurons in the rat hindbrain. Endocrinology (2010) 151:4207–13.10.1210/en.2010-029520610562
30. Mantella RC Rinaman L Vollmer RR Amico JA. Cholecystokinin and D-fenfluramine inhibit food intake in oxytocin-deficient mice. Am J Physiol Regul Integr Comp Physiol (2003) 285:R1037–45.10.1152/ajpregu.00383.200214557235
31. Atasoy D Betley JN Su HH Sternson SM. Deconstruction of a neural circuit for hunger. Nature (2012) 488:172–7.10.1038/nature1127022801496
32. Yamamoto S Morimoto I Kai K Arao T Fujihira T Morita E et al. Centrally administered murine leptin stimulates plasma arginine-vasopressin secretion and increases the level of mRNA expression in the supraoptic nucleus of conscious rats. Neuroendocrinology (1999) 70:207–12.10.1159/00005447810516484
33. Honda K Narita K Murata T Higuchi T. Leptin affects the electrical activity of neurones in the hypothalamic supraoptic nucleus. Brain Res Bull (2002) 57:721–5.10.1016/S0361-9230(01)00788-211927377
34. Velmurugan S Russell JA Leng G. Systemic leptin increases the electrical activity of supraoptic nucleus oxytocin neurones in virgin and late pregnant rats. J Neuroendocrinol (2013) 25:383–90.10.1111/jne.1201623298261
35. Seeley RJ Van Dijk G Campfield LA Smith FJ Burn P Nelligan JA et al. Intraventricular leptin reduces food intake and body weight of lean rats but not obese Zucker rats. Horm Metab Res (1996) 28:664–8.10.1055/s-2007-9798749013738
36. Halaas JL Boozer C Blair-West J Fidahusein N Denton DA Friedman JM. Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc Natl Acad Sci U S A (1997) 94:8878–83.10.1073/pnas.94.16.88789238071
37. Frederich RC Hamann A Anderson S Lollmann B Lowell BB Flier JS. Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med (1995) 1:1311–4.10.1038/nm1295-13117489415
38. Deblon N Veyrat-Durebex C Bourgoin L Caillon A Bussier AL Petrosino S et al. Mechanisms of the anti-obesity effects of oxytocin in diet-induced obese rats. PLoS One (2011) 6:e25565.10.1371/journal.pone.002556521980491
39. Maejima Y Iwasaki Y Yamahara Y Kodaira M Sedbazar U Yada T. Peripheral oxytocin treatment ameliorates obesity by reducing food intake and visceral fat mass. Aging (Albany NY) (2011) 3:1169–77.22184277
40. Zhang G Bai H Zhang H Dean C Wu Q Li J et al. Neuropeptide exocytosis involving synaptotagmin-4 and oxytocin in hypothalamic programming of body weight and energy balance. Neuron (2011) 69:523–35.10.1016/j.neuron.2010.12.03621315262
41. Morton GJ Thatcher BS Reidelberger RD Ogimoto K Wolden-Hanson T Baskin DG et al. Peripheral oxytocin suppresses food intake and causes weight loss in diet-induced obese rats. Am J Physiol Endocrinol Metab (2012) 302:E134–44.10.1152/ajpendo.00296.201122008455
42. Blevins JE Graham JL Morton GJ Bales KL Schwartz MW Baskin DG et al. Chronic oxytocin administration inhibits food intake, increases energy expenditure, and produces weight loss in fructose-fed obese rhesus monkeys. Am J Physiol (2015) 308:R431–8.10.1152/ajpregu.00441.201425540103
43. Boland D Goren HJ. Binding and structural properties of oxytocin receptors in isolated rat epididymal adipocytes. Regul Pept (1987) 18:7–18.10.1016/0167-0115(87)90045-02819958
44. Altirriba J Poher AL Caillon A Arsenijevic D Veyrat-Durebex C Lyautey J et al. Divergent effects of oxytocin treatment of obese diabetic mice on adiposity and diabetes. Endocrinology (2014) 155:4189–201.10.1210/en.2014-146625157455
45. Gajdosechova L Krskova K Olszanecki R Zorad S. Differential regulation of oxytocin receptor in various adipose tissue depots and skeletal muscle types in obese Zucker rats. Horm Metab Res (2015) 47(8):600–4.10.1055/s-0034-139567725565097
46. Plante E Menaouar A Danalache BA Yip D Broderick TL Chiasson JL et al. Oxytocin treatment prevents the cardiomyopathy observed in obese diabetic male db/db mice. Endocrinology (2015) 156(4):1416–28.10.1210/en.2014-171825562615
47. Zhang H Wu C Chen Q Chen X Xu Z Wu J et al. Treatment of obesity and diabetes using oxytocin or analogs in patients and mouse models. PLoS One (2013) 8:e61477.10.1371/journal.pone.006147723700406
48. Beranger GE Pisani DF Castel J Djedaini M Battaglia S Amiaud J et al. Oxytocin reverses ovariectomy-induced osteopenia and body fat gain. Endocrinology (2014) 155:1340–52.10.1210/en.2013-168824506069
49. Lewis GP Matthews J. The mobilization of free fatty acids from rabbit adipose tissue in situ. Br J Pharmacol (1968) 34:564–78.10.1111/j.1476-5381.1968.tb08485.x4302378
50. Goren HJ Hanif K Dudley R Hollenberg MD Lederis K. Adenosine modulation of fat cell responsiveness to insulin and oxytocin. Regul Pept (1986) 16:125–34.10.1016/0167-0115(86)90056-X3544088
51. Eriksson H Bjorgell P Akerlund M Hauksson A Melin P. Effects of a tocolytic oxytocin analogue on lipid and carbohydrate metabolism. Gynecol Obstet Invest (1990) 29:97–100.10.1159/0002933102335316
52. Wilson EJ Hollenberg MD. Effects of oxytocin and vasopressin on the preadipocyte 3T3-F442A cell line. Biochem Cell Biol (1987) 65:211–8.10.1139/o87-0272437940
53. Mukherjee SP Mukherjee C. Stimulation of pyruvate dehydrogenase activity in adipocytes by oxytocin: evidence for mediation of the insulin-like effect by endogenous hydrogen peroxide independent of glucose transport. Arch Biochem Biophys (1982) 214:211–22.10.1016/0003-9861(82)90024-8
54. Suva J Caisova D Stajner A. Modification of fat and carbohydrate metabolism by neurohypophyseal hormones. III. Effect of oxytocin on non-esterified fatty acid, glucose, triglyceride and cholesterol levels in rat serum. Endokrinologie (1980) 76:333–9.7472291
55. Yano S Kotani S Miyatake A Yamamura Y. Effect of neurohypophyseal hormones on FFA mobilization from the adipose tissue in the dehydrated rat. Endocrinol Jpn (1973) 20:345–7.10.1507/endocrj1954.20.345
56. Eckertova M Ondrejcakova M Krskova K Zorad S Jezova D. Subchronic treatment of rats with oxytocin results in improved adipocyte differentiation and increased gene expression of factors involved in adipogenesis. Br J Pharmacol (2011) 162:452–63.10.1111/j.1476-5381.2010.01037.x20846187
57. Burt RL Leake NH Dannenburg WN. Metabolic activity of oxytocin in the puerperium. Nature (1963) 198:293.10.1038/198293a0
58. Fabian E Stork A Kobilkova J Fabianova J. Inhibition of lipolysis by oxytocin and vasopressin. Acta Univ Carol Med Monogr (1977) 77:141–5.615448
59. Muchmore DB Little SA De Haen C. A dual mechanism of action of ocytocin in rat epididymal fat cells. J Biol Chem (1981) 256:365–72.
60. Field CJ Ryan EA Thomson AB Clandinin MT. Dietary fat and the diabetic state alter insulin binding and the fatty acyl composition of the adipocyte plasma membrane. Biochem J (1988) 253:417–24.3052424
61. Gajdosechova L Krskova K Segarra AB Spolcova A Suski M Olszanecki R et al. Hypooxytocinaemia in obese Zucker rats relates to oxytocin degradation in liver and adipose tissue. J Endocrinol (2014) 220:333–43.10.1530/JOE-13-041724389591
62. Shi H Bartness TJ. Neurochemical phenotype of sympathetic nervous system outflow from brain to white fat. Brain Res Bull (2001) 54:375–85.10.1016/S0361-9230(00)00455-X11306188
63. Stock S Granstrom L Backman L Matthiesen AS Uvnas-Moberg K. Elevated plasma levels of oxytocin in obese subjects before and after gastric banding. Int J Obes (1989) 13:213–22.2744933
64. Coiro V Passeri M Davoli C D’Amato L Gelmini G Fagnoni F et al. Oxytocin response to insulin-induced hypoglycemia in obese subjects before and after weight loss. J Endocrinol Invest (1988) 11:125–8.10.1007/BF033501193283208
65. Qian W Zhu T Tang B Yu S Hu H Sun W et al. Decreased circulating levels of oxytocin in obesity and newly diagnosed type 2 diabetic patients. J Clin Endocrinol Metab (2014) 99(12):4683–9.10.1210/jc.2014-220625233153
66. Szeto A Mccabe PM Nation DA Tabak BA Rossetti MA Mccullough ME et al. Evaluation of enzyme immunoassay and radioimmunoassay methods for the measurement of plasma oxytocin. Psychosom Med (2011) 73:393–400.10.1097/PSY.0b013e31821df0c221636661
67. Zhang G Zhang Y Fast DM Lin Z Steenwyk R. Ultra sensitive quantitation of endogenous oxytocin in rat and human plasma using a two-dimensional liquid chromatography-tandem mass spectrometry assay. Anal Biochem (2011) 416:45–52.10.1016/j.ab.2011.04.04121609710
68. McCullough ME Churchland PS Mendez AJ. Problems with measuring peripheral oxytocin: can the data on oxytocin and human behavior be trusted? Neurosci Biobehav Rev (2013) 37:1485–92.10.1016/j.neubiorev.2013.04.01823665533
69. Proietto J Thorburn AW. The therapeutic potential of leptin. Expert Opin Investig Drugs (2003) 12:373–8.10.1517/13543784.12.3.37312605561
70. Ott V Finlayson G Lehnert H Heitmann B Heinrichs M Born J et al. Oxytocin reduces reward-driven food intake in humans. Diabetes (2013) 62:3418–25.10.2337/db13-066323835346
71. Melis MR Stancampiano R Fratta W Argiolas A. Oxytocin concentration changes in different rat brain areas but not in plasma during aging. Neurobiol Aging (1992) 13:783–6.10.1016/0197-4580(92)90102-41491743
72. Wierda M Goudsmit E Van Der Woude PF Purba JS Hofman MA Bogte H et al. Oxytocin cell number in the human paraventricular nucleus remains constant with aging and in Alzheimer’s disease. Neurobiol Aging (1991) 12:511–6.10.1016/0197-4580(91)90081-T1770986
73. Fliers E Swaab DF. Activation of vasopressinergic and oxytocinergic neurons during aging in the Wistar rat. Peptides (1983) 4:165–70.10.1016/0196-9781(83)90108-06622286
74. Zbuzek V Fuchs AR Zbuzek VK Wu WH. Neurohypophyseal aging: differential changes in oxytocin and vasopressin release, studied in Fischer 344 and Sprague-Dawley rats. Neuroendocrinology (1988) 48:619–26.10.1159/0001250723251161
75. Chiodera P Volpi R Capretti L Caiazza A Marchesi M Caffari G et al. Oxytocin response to challenging stimuli in elderly men. Regul Pept (1994) 51:169–76.10.1016/0167-0115(94)90206-28059013
76. Elabd C Cousin W Upadhyayula P Chen RY Chooljian MS Li J et al. Oxytocin is an age-specific circulating hormone that is necessary for muscle maintenance and regeneration. Nat Commun (2014) 5:4082.10.1038/ncomms508224915299
77. Morley JE. Decreased food intake with aging. J Gerontol A Biol Sci Med Sci (2001) 56(Spec No 2):81–8.10.1093/gerona/56.suppl_2.8111730241